658Wire StoriesZip Expands into Europe and the Middle East, with the Acquisitions of European BNPL Provider Twisto and UAE-based Spotii
Dollar references are in AUD unless otherwise noted. SYDNEY & NEW YORK–(BUSINESS WIRE)–Zip Co Limited (ASX: Z1P) (“Zip” or the “Company”) is...
- 1.0KWire Stories
Toranomon-Azabudai Project and Toranomon Hills Area Project in Tokyo Precertified under LEED ND and WELL
Includes Tokyo’s First LEED ND Platinum Precertified Property and World’s Largest WELL Precertified Property TOKYO–(BUSINESS WIRE)–Mori Building Co., Ltd., Japan’s leading urban...
- 771Wire Stories
Unisantis Unveils Dynamic Flash Memory as DRAM Alternative
Benefits in higher density, speed and cost savings SINGAPORE–(BUSINESS WIRE)–Unisantis® Electronics Singapore Pte. Ltd., today unveiled the company’s developments in Dynamic Flash...
- 888Wire Stories
Hyperion Appoints Todd Hannigan as Executive Chairman
CHARLOTTE, N.C–(BUSINESS WIRE)–$HYP #criticalminerals—Hyperion Metals Limited (ASX: HYM) (“Hyperion” or “the Company”) is pleased to announce the appointment of Mr. Todd Hannigan...
- 1.3KWire Stories
MANSCAPED™ Launches in Hairhouse, Australia’s Leading Hair & Beauty Destination
The Global Leader in Men’s Below-the-Waist Grooming Debuts in its First Australian Brick-and-Mortar SAN DIEGO–(BUSINESS WIRE)–Down Under has never looked this good....
- 603Wire Stories
The Fifth World Intelligence Congress Kicks off in Tianjin With Dazzling Cutting-edge Technologies
TIANJIN, China–(BUSINESS WIRE)–The fifth World Intelligence Congress (WIC), themed “New Era of Intelligence: Empowering New Development, Fostering New Pattern”, kicked off at...
- 799Wire Stories
Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine
The agreement will further enable global supply of mRNA-1273, Moderna’s COVID-19 vaccine with Samsung Biologics’ fill and finish manufacturing service CAMBRIDGE, Mass....
- 708Wire Stories
Potential Impact of Takeda’s Dengue Vaccine Candidate Reinforced by Long-Term Safety and Efficacy Results
? Takeda’s dengue vaccine candidate (TAK-003) prevented 83.6% of hospitalizations and 62.0% of dengue illness overall, with no identified important safety risks...
- 892Wire Stories
Moderna and South Korea Explore Collaboration on mRNA Vaccines
Moderna and South Korea will explore potential areas of collaboration for research and development of mRNA vaccines and local manufacturing opportunities in...
- 741Wire Stories
Art Basel Hong Kong 2021: Digital Transformation Amidst the Pandemic
HONG KONG & LOS ANGELES–(BUSINESS WIRE)–When the 2020 edition was cancelled due to COVID-19, the future of Art Basel Hong Kong and...
